The Bulletin of Contemporary Clinical Medicine,
Journal Year:
2024,
Volume and Issue:
17(2), P. 124 - 129
Published: April 1, 2024
Introduction.
Phosphate
diabetes
is
a
representative
of
group
diseases
known
as
tubulopathies.
It
more
often
hereditary
nature.
The
disease
manifests
at
an
early
age
with
symptoms
similar
to
alimentary
rickets,
which
creates
problems
for
diagnosing
and
prescribing
adequate
therapy.
In
this
case,
the
current
situation
leads
development
bone
deformities
disability,
delayed
physical
development,
need
surgical
treatment,
reduces
quality
life
patients
long
time.
Aim:
To
consider
two
clinical
cases
phosphate
typical
symptoms,
demonstrate
challenges,
analyze
treatment
effects.
Materials
Methods.
Two
are
presented.
first
patient:
16
years
old,
observed
from
2,
takes
vitamin
D
inorganic
phosphates
diagnosis
date.
geneticist
found
autosomal
dominant
pathology.
girl
underwent
surgeries
her
leg
deformity.
second
patient,
10
was
diagnosed
4
years.
DNA
diagnostics
detected
mutation
in
COL9A3
gene.
They
refused
complete
exome
sequencing.
From
date,
patient
treated
active
metabolite
phosphates.
Results
Discussion.
Clinician-observed:
Patient
1
had
deformities,
painful
legs,
disharmonious
caused
by
growth
retardation.
Blood
concentrations
calcium
phosphorus
within
normal,
there
hypocalciuria
urine,
while
normal.
patient’s
kidney
function
not
impaired.
2
physically
retarded,
varus
foot
pes
planovalgus
feet.
Kidney
impaired,
level
alkaline
phosphatase
increased,
total
blood
levels
decreased
indicating
normal
values,
urine
phosphaturia
ranges.
Due
detected,
Stickler
syndrome
excluded.
Orthopedic
surgeon
recommended
deformities.
Conclusions.
examination
showed
that
therapy
allows
keeping
under
control
avoiding
side
effects
taking
D.
Cellular Signalling,
Journal Year:
2024,
Volume and Issue:
119, P. 111156 - 111156
Published: April 2, 2024
In
the
seemingly
well-researched
field
of
vascular
research,
there
are
still
many
underestimated
factors
and
molecular
mechanisms.
recent
years,
SUMOylation
has
become
increasingly
important.
is
a
post-translational
modification
in
which
small
ubiquitin-related
modifiers
(SUMO)
covalently
attached
to
target
proteins.
Sites
where
these
SUMO
processes
take
place
cell
nucleus
PML
nuclear
bodies
(PML-NBs)
-
multiprotein
complexes
with
their
essential
main
component
organizer,
protein.
SUMO,
either
alone
or
as
partners,
influence
variety
cellular
processes,
including
regulation
transcription,
senescence,
DNA
damage
response
defence
against
microorganisms,
involved
innate
immunity
inflammatory
responses.
They
also
play
an
important
role
maintaining
homeostasis
system
pathological
leading
development
progression
cardiovascular
diseases.
This
review
summarizes
information
about
function
SUMO(ylation)
PML(-NBs)
human
vasculature
from
angiogenesis
disease
highlights
clinical
potential
drug
targets.
The Bulletin of Contemporary Clinical Medicine,
Journal Year:
2024,
Volume and Issue:
17(2), P. 104 - 111
Published: April 1, 2024
Introduction.
Obesity
is
classified
as
a
long-term
condition
with
various
causes
and
manifestations
represents
disproportionate
accumulation
of
fat
deposits
in
human
body.
It
shown
that
overweight
reduces
the
life
expectancy
increases
likelihood
multiple
diseases,
even
young
people.
especially
important
to
pay
attention
people
suffering
from
extreme
obesity.
This
term
refers
which
body
mass
index
exceeds
40
kg/m2.
One
methods
combat
this
may
be
bariatric
intervention.
Procedures
for
adjusting
drug
therapy
patients
after
surgery
are
common
have
already
proven
their
effectiveness.
Medication
management
techniques
help
improve
patient
care
throughout
entire
treatment
process,
preparatory
phase
time
ready
leave
hospital.
The
aim
our
study
was
systematize
approaches
who
undergone
surgery.
Materials
Methods.
object
Methodology
based
on
scientific
medical
publications
field
statistical
studies.
50
electronic
libraries
were
studied
analyzed,
such
eLibrary,
Pubmed,
Cyberlenika,
Google
Scholar
2010
2020
present.
Results
Discussion.
In
had
taken
vitamins
minerals
basis,
there
an
improvement
quality
life,
integrated
approach
obesity
developed,
reduction
found
concomitant
risks.
Conclusions.
paper
describes
practical
characteristics
surgery,
makes
it
possible
more
clearly
determine
strategy
rehabilitation
future
lifestyle.
The Bulletin of Contemporary Clinical Medicine,
Journal Year:
2024,
Volume and Issue:
17(2), P. 64 - 70
Published: April 1, 2024
Introduction.
Type
D
personality,
or
distress
i.
e.,
a
combination
of
negative
affectivity
and
social
inhibition,
as
well
poor
life
quality,
are
considered
the
predictors
cardiovascular
morbidity
mortality.
However,
there
is
insufficient
data
on
role
personality
determinant
quality
in
myocardial
infarction
patients.
Aim
to
assess
Q-positive
patients’
its
association
with
personality.
Materials
Methods.
The
study
included
158
patients
aged
58.2±2.5
years,
who
were
admitted
hospital
for
ST-segment
elevation
infarction.
was
diagnosed
accordance
Clinical
Guidelines
Russian
Society
Cardiology,
2020.
Пациентам
анализируемых
групп
проведено
определение
общеклинических
параметров,
психологическое
тестирование
с
применением
оценочных
шкал
тревоги
и
депрессии,
опросников
DS-14
SF-36.
Patients
groups
studied
tested
general
clinical
parameters
psychological
characteristics
using
anxiety
depression
rating
scales,
SF-36
questionnaires.
Individuals
without
identified
group
Results
Discussion.
detected
29.1%
In
this
group,
an
unfavorable
profile
noted:
Their
excitability,
suppression,
depression,
personal/situational
levels
higher
than
lower
decrease
integral
indicators
physical
psychologic
components.
Conclusions.
proven
provide
adverse
effect
Cardiac
rehabilitation
programs
should
include
interventions
reduce
traits,
especially
inhibition.
The Bulletin of Contemporary Clinical Medicine,
Journal Year:
2024,
Volume and Issue:
17(2), P. 118 - 123
Published: April 1, 2024
Introduction.
Over
decades,
chronic
heart
failure
has
remained
one
of
the
most
pressing
health
problems
in
developed
countries,
including
Russian
Federation.
New
methods
are
being
actively
and
implemented
to
enable
early
diagnosis
stratification
risk.
A
particular
importance
is
attached
search
for
markers
that
allow
very
accurately
predicting
course
disease.
In
recent
years,
galectin-3
a
novel
heart-failure
biomarker.
Aim.
This
study
was
aimed
at
analyzing
modern
scientific
research
publications
dealing
with
role
pathogenesis
possibility
using
it
as
Material
Methods.
foreign
literary
sources
were
analyzed,
related
issues
under
over
years
2002-2023.
Results
Discussion.
Galectin-3
beta-galactoside-binding
lectin
secreted
human
tissue
by
macrophages.
an
important
factor
pathophysiology,
mainly
because
its
remodeling
ventricles,
due
activation
fibroblasts
collagen
secretion,
which
excessively
deposited
around
cardiomyocytes.
Various
studies
conducted
had
demonstrated
positive
correlation
between
level
damage
degree,
particularly
left
ventricle.
Studying
patients
frailty
also
showed
relationship
severity.
Sarcopenic
obesity
suffering
from
significantly
worsens
their
prognosis.
Conclusions.
Analysis
available
literature
data
allows
us
consider
structurally
unique
functionally
compound
expressed
various
tissues
cells
body.
plasma
positively
correlates
severity
changes
structure
functions.
Thus,
may
be
promising
biomarker
occurrence
progression.
The Bulletin of Contemporary Clinical Medicine,
Journal Year:
2024,
Volume and Issue:
17(2), P. 124 - 129
Published: April 1, 2024
Introduction.
Phosphate
diabetes
is
a
representative
of
group
diseases
known
as
tubulopathies.
It
more
often
hereditary
nature.
The
disease
manifests
at
an
early
age
with
symptoms
similar
to
alimentary
rickets,
which
creates
problems
for
diagnosing
and
prescribing
adequate
therapy.
In
this
case,
the
current
situation
leads
development
bone
deformities
disability,
delayed
physical
development,
need
surgical
treatment,
reduces
quality
life
patients
long
time.
Aim:
To
consider
two
clinical
cases
phosphate
typical
symptoms,
demonstrate
challenges,
analyze
treatment
effects.
Materials
Methods.
Two
are
presented.
first
patient:
16
years
old,
observed
from
2,
takes
vitamin
D
inorganic
phosphates
diagnosis
date.
geneticist
found
autosomal
dominant
pathology.
girl
underwent
surgeries
her
leg
deformity.
second
patient,
10
was
diagnosed
4
years.
DNA
diagnostics
detected
mutation
in
COL9A3
gene.
They
refused
complete
exome
sequencing.
From
date,
patient
treated
active
metabolite
phosphates.
Results
Discussion.
Clinician-observed:
Patient
1
had
deformities,
painful
legs,
disharmonious
caused
by
growth
retardation.
Blood
concentrations
calcium
phosphorus
within
normal,
there
hypocalciuria
urine,
while
normal.
patient’s
kidney
function
not
impaired.
2
physically
retarded,
varus
foot
pes
planovalgus
feet.
Kidney
impaired,
level
alkaline
phosphatase
increased,
total
blood
levels
decreased
indicating
normal
values,
urine
phosphaturia
ranges.
Due
detected,
Stickler
syndrome
excluded.
Orthopedic
surgeon
recommended
deformities.
Conclusions.
examination
showed
that
therapy
allows
keeping
under
control
avoiding
side
effects
taking
D.